Pneumonia Market, Global Outlook and Forecast 2023-2030

11 December 2023
Life Sciences
62 Pages
Report code : PMR-7873758

4.7

(158)

Download Free PDF sample

Pneumonia Market

Download FREE Report Sample

Download Free sample

The global Pneumonia market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Pneumonia market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Pneumonia market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Pneumonia market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
Pneumonia Market aims to provide a comprehensive presentation of the global market for Pneumonia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia. Pneumonia Market contains market size and forecasts of Pneumonia in global, including the following market information:

Global Pneumonia Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)

Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.
We surveyed the Pneumonia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pneumonia Market, by Type, 2018-2023, 2024-2030 ($ millions)

Global Pneumonia Market Segment Percentages, by Type, 2022 (%)

Drugs
Vaccines
Oxygen Therapy

Global Pneumonia Market, by Application, 2018-2023, 2024-2030 ($ millions)

Global Pneumonia Market Segment Percentages, by Application, 2022 (%)

Hospitals
Ambulatory Surgical Centers
Others

Global Pneumonia Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)

Global Pneumonia Market Segment Percentages, By Region and Country, 2022 (%)

North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
The Middle East and Africa (Middle East, Africa)
South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pneumonia revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pneumonia revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly

Outline of Major Chapters:
Chapter 1: Introduces the definition of Pneumonia, market overview.
Chapter 2: Global Pneumonia market size in revenue.
Chapter 3: Detailed analysis of Pneumonia company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pneumonia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

CHECK TODAYS BEST PRICE

Request
Chapter Price

Download
Free Sample

SECURITY ASSURED payment image

Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research

Frequently Asked Questions ?

User License

A license granted to one user.
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
Multi user License
A license granted to multiple users.
Site License
A license granted to a single business site/establishment.
Corporate License, Global License
A license granted to all employees within organisation access to the product.

Delivery Time

Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

WHY CHOOSE US

Proactive We manage our resources 24/7 to identify issues and address them before they become problems
Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach 6 Major regions and 40+ countries level analysis accomplished
Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery